Cancer Research Cell Death Mechanisms and Cancer Therapy  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 5514-5520, November 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R. K.
Right arrow Articles by Harrington, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R. K.
Right arrow Articles by Harrington, W. J., Jr.
[Cancer Research 59, 5514-5520, November 1, 1999]
© 1999 American Association for Cancer Research


Experimental Therapeutics

Azidothymidine and Interferon-{alpha} Induce Apoptosis in Herpesvirus-associated Lymphomas1

Richard K. Lee2, Jian-Ping Cai2, Vadim Deyev, Parkash S. Gill, Lisa Cabral, Charles Wood, Ram P. Agarwal, Wenle Xia, Lawrence H. Boise, Eckhard Podack and William J. Harrington, Jr.3

Department of Microbiology and Immunology [R. K. L., V. D., L. H. B., E. P.] and Division of Hematology/Oncology, Department of Medicine [J-P. C., L. C., R. P. A., W. X., W. J. H.], University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida 33136; Departments of Medicine and Pathology, University of Southern California, Los Angeles, California 90033 [P. S. G.]; and Department of Microbiology and Immunology, University of Nebraska, Lincoln, Nebraska 68588 [C. W.]

Lymphoproliferative diseases that occur in immunocompromised patients are frequently associated with herpesviruses. These patients often fare poorly after treatment with conventional chemotherapy. We reported previously that patients with AIDS-related Burkitt’s lymphoma (BL) responded to parenteral azidothymidine (AZT) and IFN-{alpha}. We found that EBV-positive lymphoma cells derived from these patients cultured with AZT express CD95 and undergo apoptosis. AZT-mediated apoptosis was caspase dependent and occurred despite Fas receptor blockade. In contrast, EBV-negative lymphomas were resistant to AZT-induced apoptosis, as were EBV-positive lymphomas that expressed high levels of bcl-2. Primary effusion lymphoma (PEL) cell lines infected with human herpesvirus type 8 required IFN-{alpha} to potentiate AZT-induced apoptosis. IFN-{alpha} did not up-regulate CD95 in BL or PEL but did induce expression of the death receptor ligand, CD95 ligand. AZT-sensitive lymphomas also accumulated significantly higher intracellular AZT monophosphate than did resistant lymphomas. Our data demonstrated distinct apoptotic responses to AZT and IFN-{alpha} in herpesvirus-associated lymphomas. EBV-positive BL cells that expressed low BCL-2 levels were sensitive to AZT alone; PEL cells required the addition of IFN-{alpha} to enhance apoptosis, and EBV-negative lymphomas were insensitive to both agents. AZT-sensitive BL cells transfected with BCL-2 became resistant. Susceptibility to antivirus-mediated apoptosis may be exploited to improve the therapy of certain herpesvirus-associated lymphomas.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. A. Davis, K. E. Singer, I. P. Reynolds, M. Haque, and R. Yarchoan
Hypoxia Enhances the Phosphorylation and Cytotoxicity of Ganciclovir and Zidovudine in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells
Cancer Res., July 15, 2007; 67(14): 7003 - 7010.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Datta, M. Bellon, U. Sinha-Datta, A. Bazarbachi, Y. Lepelletier, D. Canioni, T. A. Waldmann, O. Hermine, and C. Nicot
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
Blood, August 1, 2006; 108(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
G Galli, R Zonefrati, A Gozzini, C Mavilia, V Martineti, I Tognarini, G Nesi, T Marcucci, F Tonelli, M Tommasi, et al.
Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma.
Endocr. Relat. Cancer, March 1, 2006; 13(1): 79 - 93.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. B. Gill, J.-E. Murphy, and J. D. Fingeroth
Functional Divergence of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-2 Herpesvirus Thymidine Kinases: Novel Cytoplasmic Phosphoproteins That Alter Cellular Morphology and Disrupt Adhesion
J. Virol., December 1, 2005; 79(23): 14647 - 14659.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Staudt, Y. Kanan, J. H. Jeong, J. F. Papin, R. Hines-Boykin, and D. P. Dittmer
The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo
Cancer Res., July 15, 2004; 64(14): 4790 - 4799.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Ghosh, C. Wood, L. H. Boise, A. M. Mian, V. V. Deyev, G. Feuer, N. L. Toomey, N. C. Shank, L. Cabral, G. N. Barber, et al.
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B
Blood, March 15, 2003; 101(6): 2321 - 2327.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. K. Baker, A. R. Pettitt, J. R. Slupsky, H. J. Chen, M. A. Glenn, M. Zuzel, and J. C. Cawley
Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion
Blood, June 28, 2002; 100(2): 647 - 653.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.